IRIS
LUCARELLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.231
NA - Nord America 2.161
EU - Europa 1.430
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 67
OC - Oceania 3
Totale 6.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.067
SG - Singapore 952
RU - Federazione Russa 718
VN - Vietnam 461
CN - Cina 435
BR - Brasile 202
IT - Italia 183
HK - Hong Kong 136
DE - Germania 126
GB - Regno Unito 97
FR - Francia 95
NL - Olanda 71
IN - India 58
FI - Finlandia 44
CA - Canada 43
AR - Argentina 32
KR - Corea 32
JP - Giappone 30
MX - Messico 28
BD - Bangladesh 22
ZA - Sudafrica 19
CI - Costa d'Avorio 18
PH - Filippine 14
PL - Polonia 13
TH - Thailandia 13
UA - Ucraina 12
AT - Austria 10
ES - Italia 10
IQ - Iraq 10
TR - Turchia 10
ID - Indonesia 9
PK - Pakistan 9
LT - Lituania 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
EG - Egitto 6
JM - Giamaica 6
SE - Svezia 6
UZ - Uzbekistan 6
DK - Danimarca 5
IR - Iran 5
MA - Marocco 5
PY - Paraguay 5
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
IE - Irlanda 4
JO - Giordania 4
LV - Lettonia 4
NP - Nepal 4
VE - Venezuela 4
AU - Australia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
IM - Isola di Man 1
KZ - Kazakistan 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MW - Malawi 1
NE - Niger 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.156
Salva come PNG Salva come JPEG
Città #
Singapore 477
San Jose 374
Ashburn 234
Moscow 162
Hefei 137
Hong Kong 132
Chandler 126
Ho Chi Minh City 121
Beijing 116
Hanoi 91
Santa Clara 81
Council Bluffs 65
Naples 65
Amsterdam 63
Los Angeles 58
Munich 58
Dong Ket 56
The Dalles 52
Lauterbourg 47
Enfield 41
New York 38
Millbury 31
Dallas 28
Frankfurt am Main 27
Turku 26
Kochi 25
Redondo Beach 25
Seoul 25
Tokyo 25
Lawrence 24
Buffalo 22
Des Moines 22
Boston 21
São Paulo 20
Haiphong 19
London 19
Phoenix 18
Da Nang 16
Orem 16
Chicago 14
Milan 13
Atlanta 12
Mexico City 12
Helsinki 11
Johannesburg 11
Montreal 11
Ottawa 11
Seattle 11
Warsaw 11
Houston 10
Bari 9
Chennai 9
Denver 9
Napoli 9
Nuremberg 9
Biên Hòa 8
Brooklyn 8
Toronto 8
Wilmington 8
Lappeenranta 7
Paris 7
Baghdad 6
Düsseldorf 6
Fairfield 6
Ha Long 6
Nanjing 6
Ninh Bình 6
Philadelphia 6
Pune 6
Vienna 6
Ankara 5
Belo Horizonte 5
Cairo 5
Can Tho 5
Guangzhou 5
Kronberg 5
Poplar 5
Princeton 5
Rome 5
San Francisco 5
Shanghai 5
Amman 4
Bangkok 4
Bexley 4
Boardman 4
Bắc Giang 4
Concepción 4
Dearborn 4
Dhaka 4
Dublin 4
Manchester 4
Riga 4
Siziano 4
St Louis 4
Stockholm 4
Tashkent 4
Washington 4
Woodbridge 4
Augusta 3
Bengaluru 3
Totale 3.404
Salva come PNG Salva come JPEG
Nome #
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 295
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 211
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 177
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 176
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 166
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 164
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 161
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 159
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 159
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 152
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 149
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 149
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 147
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 147
Beyond PSA: The Role of Prostate Health Index (phi) 146
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 146
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 145
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 144
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 140
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 139
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 137
Prostate cancer radiogenomics—from imaging to molecular characterization 137
The evolving landscape of renal surgery for complex renal masses (CRM): implications for oncologic and functional outcomes 134
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 132
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 130
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 129
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 128
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 126
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 126
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 126
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 125
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 124
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 123
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 123
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 122
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 122
Radiomics in prostate cancer: an up-to-date review 120
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 112
Quality of Web-Based Patient Information on Robotic Radical Cystectomy Remains Poor: A Standardized Assessment 106
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 105
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 77
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up 76
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 72
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 69
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 64
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 61
Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis 55
Totale 6.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022182 0 3 4 0 2 2 1 3 6 22 70 69
2022/2023436 29 11 16 7 50 38 1 41 60 128 53 2
2023/2024290 6 55 60 22 16 15 5 38 5 2 51 15
2024/20251.649 64 80 0 11 53 61 160 88 133 221 654 124
2025/20263.141 339 288 354 311 495 143 391 154 355 182 75 54
2026/2027339 229 110 0 0 0 0 0 0 0 0 0 0
Totale 6.233